The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by HAMILTON, C. S.
* Articles by SWEDO, S. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by HAMILTON, C. S.
* Articles by SWEDO, S. E.
Related Collections
* Tourette's
* Other Childhood Disorders
* Eating Disorders
* Obsessive-Compulsive Disorder
* Other Diagnostic Tools
* Molecular Biology
* Other Research Techniques
Am J Psychiatry 160:1193-1194, June 2003
© 2003 American Psychiatric Association


Letter to the Editor

Sensitivity of the D8/17 Assay

CHARLOTTE S. HAMILTON, M.D., MARJORIE A. GARVEY, M.D., and SUSAN E. SWEDO, M.D.
Bethesda, Md.

To the Editor: Mae S. Sokol, M.D., and colleagues (1) recently reported a significantly higher rate of D8/17 positivity among 16 adolescents with anorexia nervosa (81%) than among 17 psychiatric comparison subjects (12%). The mean percentage of D8/17 positivity might "be useful in identifying PANDAS [pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections] anorexia nervosa" (p. 1431). The results of that investigation are similar to findings in two previous studies (2, 3) demonstrating excellent performance of the D8/17 assay in distinguishing patients with obsessive-compulsive disorder (OCD) from healthy comparison subjects—85% to 100% of OCD patients were D8/17 positive in comparison with 5% to 15% of healthy comparison subjects. However, our subsequent experience has been less satisfactory and suggests that the assay is not yet reliable enough to be used as a diagnostic tool.

In our work, a total of 216 samples were gathered over a 4-year period from 26 subjects with Sydenham’s chorea, 42 subjects with OCD and/or tic disorders (PANDAS subgroup), and 19 healthy comparison subjects. Samples were obtained at the National Institute for Mental Health (NIMH) by workers blind to patient diagnosis and sent to Rockefeller University, where assays were performed by immunofluorescent microscopy before August 1998 and subsequently by flow cyometry, according to methods previously reported (4). Written informed consent or assent was obtained from all subjects, who were participating in studies of Sydenham’s chorea and OCD that were approved by NIMH institutional review boards.

Overall, the sensitivity of the D8/17 assay for the 68 patients with Sydenham’s chorea or OCD/tics was 61.8% (42 assays were positive). Of concern, only 12 assays (46.2%) obtained from the 26 Sydenham’s chorea patients were positive, which is significantly lower (z=5.2, p<0.001) than that previously reported for patients with rheumatic fever (89%–100% were D8/17 positive) (5, 6). Thus, the D8/17 assay failed to "diagnose" the majority of the patients with Sydenham’s chorea. Furthermore, the reliability of the assay was suboptimal. Longitudinal observations of 54 subjects tested at random intervals over the study period demonstrated test-retest agreement of 61.1% (N=132) for the 216 samples assayed (kappa=0.18). Of particular concern, agreement was observed in only 48 of 61 split samples (78.7%, kappa=0.48).

In conclusion, the sensitivity of the D8/17 assay decreased to unacceptably low levels during the period of observation. The declining sensitivity may have been due to changes in methods or the characteristics of the monoclonal antibody. If so, the performance might be improved by reversion to earlier techniques. Meanwhile, it appears premature to include the D8/17 assay in the diagnostic workup of patients with neuropsychiatric disorders such as OCD, tics, and anorexia nervosa.

References

  1. Sokol MS, Ward PE, Tamiya H, Kondo DG, Houston D, Zabriskie JB: D8/17 expression on B lymphocytes in anorexia nervosa. Am J Psychiatry 2002; 159:1430-1432[Abstract/Free Full Text]
  2. Swedo SE, Leonard HL, Mittleman BB, Allen AJ, Rapoport JL, Dow SP, Kanter ME, Chapman F, Zabriskie J: Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997; 154:110-112[Abstract]
  3. Murphy TK, Goodman WK, Fudge MW, Williams RC Jr, Ayoub EM, Dalal M, Lewis MH, Zabriskie JB: B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette’s syndrome? Am J Psychiatry 1997; 154:402-407[Abstract]
  4. Chapman F, Visvanathan K, Carreno-Manjarrez R, Zabriskie JB: A flow cytometric assay for D8/17 B cell marker in patients with Tourette’s syndrome and obsessive compulsive disorder. J Immunol Methods 1998; 219:181-186[CrossRef][Medline]
  5. Khanna AK, Buskirk DR, Williams RC Jr, Gibofsky A, Crow MK, Menon A, Fotino M, Reid HM, Poon-King T, Rubinstein P, Zabriskie JB: Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 1989; 83:1710-1716
  6. Gibofsky A, Khanna A, Suh E, Zabriskie JB: The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease. J Rheumatol Suppl 1991; 30:1-5[Medline]



This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
P. J. HOEKSTRA, J. BIJZET, P. C. LIMBURG, C. G.M. KALLENBERG, and R. B. MINDERAA
Elevated Binding of D8/17-Specific Monoclonal Antibody to B Lymphocytes in Tic Disorder Patients
Am J Psychiatry, August 1, 2004; 161(8): 1501 - 1502.
[Full Text] [PDF]


Home page
CVIHome page
J. L. Weisz, W. M. McMahon, J. C. Moore, N. H. Augustine, J. F. Bohnsack, J. F. Bale, M. B. Johnson, J. F. Morgan, J. Jensen, L. Y. Tani, et al.
D8/17 and CD19 Expression on Lymphocytes of Patients with Acute Rheumatic Fever and Tourette's Disorder
Clin. Vaccine Immunol., March 1, 2004; 11(2): 330 - 336.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
T. L. Sweeten, S. L. Bowyer, D. J. Posey, G. M. Halberstadt, and C. J. McDougle
Increased Prevalence of Familial Autoimmunity in Probands With Pervasive Developmental Disorders
Pediatrics, November 1, 2003; 112(5): e420 - 420.
[Abstract] [Full Text] [PDF]


This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by HAMILTON, C. S.
* Articles by SWEDO, S. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by HAMILTON, C. S.
* Articles by SWEDO, S. E.
Related Collections
* Tourette's
* Other Childhood Disorders
* Eating Disorders
* Obsessive-Compulsive Disorder
* Other Diagnostic Tools
* Molecular Biology
* Other Research Techniques


Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org